The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-18
DOI
10.1038/s41573-020-00093-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibodies from Lampreys as Smart Anti-Glycan Reagents (SAGRs): Perspectives on Their Specificity, Structure, and Glyco-genomics
- (2020) Tanya R. McKitrick et al. BIOCHEMISTRY
- Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients
- (2020) Alessandra Battaglia et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study
- (2020) Molly Brewer et al. GYNECOLOGIC ONCOLOGY
- On‐Chip Neo‐Glycopeptide Synthesis for Multivalent Glycan Presentation
- (2020) Marco Mende et al. CHEMISTRY-A EUROPEAN JOURNAL
- Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance
- (2020) Valerie Barbier et al. Nature Communications
- Optimal Dissociation Methods Differ for N- and O-Glycopeptides
- (2020) Nicholas M. Riley et al. JOURNAL OF PROTEOME RESEARCH
- Targeted glycan degradation potentiates the anticancer immune response in vivo
- (2020) Melissa A. Gray et al. Nature Chemical Biology
- Anti–Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis
- (2020) Evan S. Dellon et al. NEW ENGLAND JOURNAL OF MEDICINE
- A versatile soluble siglec scaffold for sensitive and quantitative detection of glycan ligands
- (2020) Emily Rodrigues et al. Nature Communications
- Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)
- (2019) Franck Morschhauser et al. Lancet Haematology
- Dual actions of group B Streptococcus capsular sialic acid provide resistance to platelet-mediated antimicrobial killing
- (2019) Satoshi Uchiyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
- (2019) Stacy A. Malaker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
- (2019) Jun Wang et al. NATURE MEDICINE
- CD33 recruitment inhibits IgE-mediated anaphylaxis and desensitizes mast cells to allergen
- (2019) Shiteng Duan et al. JOURNAL OF CLINICAL INVESTIGATION
- Effects of CD33 Variants on Neuroimaging Biomarkers in Non-Demented Elders
- (2019) Ya-Juan Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
- (2019) John V. Pluvinage et al. NATURE
- Bone vascular niche E-selectin induces mesenchymal–epithelial transition and Wnt activation in cancer cells to promote bone metastasis
- (2019) Mark Esposito et al. NATURE CELL BIOLOGY
- Siglec-9 Regulates an Effector Memory CD8+ T-cell Subset That Congregates in the Melanoma Tumor Microenvironment
- (2019) Quentin Haas et al. Cancer Immunology Research
- Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy
- (2019) Heng-Huan Lee et al. CANCER CELL
- An Atlas of Human Glycosylation Pathways Enables Display of the Human Glycome by Gene Engineered Cells
- (2019) Yoshiki Narimatsu et al. MOLECULAR CELL
- CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
- (2019) Amira A. Barkal et al. NATURE
- TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer’s Disease
- (2019) Ana Griciuc et al. NEURON
- Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy
- (2019) Barbara Muz et al. Blood Cancer Journal
- High E-Selectin Ligand Expression Contributes to Chemotherapy-Resistance in Poor Risk Relapsed and Refractory (R/R) Acute Myeloid Leukemia (AML) Patients and Can be Overcome with the Addition of Uproleselan
- (2019) Daniel J. DeAngelo et al. BLOOD
- Identification of lipophilic ligands of Siglec5 and -14 that modulate innate immune responses
- (2019) Rie Suematsu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- VISTA is an acidic pH-selective ligand for PSGL-1
- (2019) Robert J. Johnston et al. NATURE
- A novel, fully human anti-fucosyl-GM1 antibody demonstrates potent in vitro and in vivo antitumor activity in preclinical models of small cell lung cancer
- (2018) Paul Ponath et al. CLINICAL CANCER RESEARCH
- Investigational CD33-targeted therapeutics for acute myeloid leukemia
- (2018) Roland B. Walter EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Distinct human α(1,3)-fucosyltransferases drive Lewis-X/sialyl Lewis-X assembly in human cells
- (2018) Nandini Mondal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Galectins at a glance
- (2018) Ludger Johannes et al. JOURNAL OF CELL SCIENCE
- Next generation of immune checkpoint therapy in cancer: new developments and challenges
- (2018) Julian A. Marin-Acevedo et al. Journal of Hematology & Oncology
- Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
- (2018) Christopher W. Mount et al. NATURE MEDICINE
- Structure-based discovery of glycomimetic FmlH ligands as inhibitors of bacterial adhesion during urinary tract infection
- (2018) Vasilios Kalas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical Trials and Applications of Galectin Antagonists
- (2018) Armand Girard et al. TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY
- Cell-based glycan arrays for probing glycan–glycan binding protein interactions
- (2018) Jennie Grace Briard et al. Nature Communications
- Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers
- (2018) Xiaodong Sun et al. BMC CANCER
- Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells
- (2018) Michal A. Stanczak et al. JOURNAL OF CLINICAL INVESTIGATION
- Siglec-7 engagement by GBS β-protein suppresses pyroptotic cell death of natural killer cells
- (2018) Jerry J. Fong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysis
- (2018) Abdullah Kutlar et al. AMERICAN JOURNAL OF HEMATOLOGY
- A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia
- (2018) David R. Spiciarich et al. CANCER RESEARCH
- Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma
- (2018) Sophie Poty et al. CLINICAL CANCER RESEARCH
- Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?
- (2018) Francesco Panza et al. Immunotherapy
- Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties
- (2017) Huifeng Yu et al. GLYCOBIOLOGY
- Targeting the PSGL-1 pathway for immune modulation
- (2017) Roberto Tinoco et al. Immunotherapy
- Extrinsic sialylation is dynamically regulated by systemic triggersin vivo
- (2017) Charles T. Manhardt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of Siglec Ligands Using a Proximity Labeling Method
- (2017) Lanyi Chang et al. JOURNAL OF PROTEOME RESEARCH
- Development of IsoTaG, a Chemical Glycoproteomics Technique for Profiling Intact N- and O-Glycopeptides from Whole Cell Proteomes
- (2017) Christina M. Woo et al. JOURNAL OF PROTEOME RESEARCH
- Safety and efficacy of the antiganglioside GD3 antibody ecromeximab (KW2871) combined with high-dose interferon-α2b in patients with metastatic melanoma
- (2017) Ahmad A. Tarhini et al. MELANOMA RESEARCH
- CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
- (2017) Terry J Fry et al. NATURE MEDICINE
- Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
- (2017) Kenneth I. Ataga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhighneutrophils
- (2017) Camilla Engblom et al. SCIENCE
- Molecular basis of human CD22 function and therapeutic targeting
- (2017) June Ereño-Orbea et al. Nature Communications
- Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects
- (2017) Laura F. Hutchins et al. Oncotarget
- Recent Advance in Tumor-associated Carbohydrate Antigens (TACAs)-based Antitumor Vaccines
- (2016) Danyang Feng et al. ACS Chemical Biology
- Dinutuximab
- (2016) Cady Ploessl et al. ANNALS OF PHARMACOTHERAPY
- Sevuparin binds to multiple adhesive ligands and reduces sickle red blood cell-induced vaso-occlusion
- (2016) Marilyn J. Telen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Hyaluronan: A modulator of the tumor microenvironment
- (2016) Theerawut Chanmee et al. CANCER LETTERS
- Polysialic acid blocks mononuclear phagocyte reactivity, inhibits complement activation, and protects from vascular damage in the retina
- (2016) Marcus Karlstetter et al. EMBO Molecular Medicine
- Fulfilling Koch's postulates in glycoscience: HCELL, GPS and translational glycobiology
- (2016) Robert Sackstein GLYCOBIOLOGY
- Biological roles of glycans
- (2016) Ajit Varki GLYCOBIOLOGY
- Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma
- (2016) Avery D. Posey et al. IMMUNITY
- Effects of P-Selectin Antagonist Inclacumab in Patients Undergoing Coronary Artery Bypass Graft Surgery
- (2016) Barbara E. Stähli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9
- (2016) Richard Beatson et al. NATURE IMMUNOLOGY
- Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
- (2016) Hagop M. Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Precision glycocalyx editing as a strategy for cancer immunotherapy
- (2016) Han Xiao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- P-selectin is a nanotherapeutic delivery target in the tumor microenvironment
- (2016) Y. Shamay et al. Science Translational Medicine
- Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone
- (2016) Trevor T. Price et al. Science Translational Medicine
- Effects of the P‐Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT‐ACS Trial
- (2016) Barbara E. Stähli et al. Journal of the American Heart Association
- A Phase I Study of Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission
- (2016) Roisin O’Cearbhaill et al. Cancers
- Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use
- (2015) M. J. Telen et al. BLOOD
- Selectins: initiators of leucocyte adhesion and signalling at the vascular wall
- (2015) Rodger P. McEver CARDIOVASCULAR RESEARCH
- Host and pathogen hyaluronan signal through human siglec-9 to suppress neutrophil activation
- (2015) Ismael Secundino et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia
- (2015) S S Kenderian et al. LEUKEMIA
- Association of Alzheimer's disease GWAS loci with MRI markers of brain aging
- (2015) Ganesh Chauhan et al. NEUROBIOLOGY OF AGING
- A Phase I Study of the Anti-Idiotype Vaccine Racotumomab in Neuroblastoma and Other Pediatric Refractory Malignancies
- (2015) Walter Cacciavillano et al. PEDIATRIC BLOOD & CANCER
- Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer
- (2015) Jacob L. Houghton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Siglecs with a sialic acid–decorated nanoparticle abrogates inflammation
- (2015) Shaun Spence et al. Science Translational Medicine
- Glycopeptide analogues of PSGL-1 inhibit P-selectin in vitro and in vivo
- (2015) Venkata R. Krishnamurthy et al. Nature Communications
- The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic
- (2015) Elizabeth S. Gabitzsch et al. Oncotarget
- Anti-inflammatory activity of low molecular weight polysialic acid on human macrophages
- (2015) Anahita Shahraz et al. Scientific Reports
- Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: Results of the ALFA-0701 trial
- (2015) Aline Renneville et al. Oncotarget
- Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice
- (2014) T. Toubai et al. BLOOD
- Immunological response induced by abagovomab as a maintenance therapy in patients with epithelial ovarian cancer: relationship with survival—a substudy of the MIMOSA trial
- (2014) Alexia Buzzonetti et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Globo-H Ceramide Shed from Cancer Cells Triggers Translin-Associated Factor X-Dependent Angiogenesis
- (2014) J.-Y. Cheng et al. CANCER RESEARCH
- Phase I Trial of a Bivalent Gangliosides Vaccine in Combination with β-Glucan for High-Risk Neuroblastoma in Second or Later Remission
- (2014) Brian H. Kushner et al. CLINICAL CANCER RESEARCH
- A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients
- (2014) S. Alfonso et al. CLINICAL CANCER RESEARCH
- Siglec-7 is an inhibitory receptor on human mast cells and basophils
- (2014) Sa'ar Mizrahi et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mechanism and Function of Monoclonal Antibodies Targeting Siglec-15 for Therapeutic Inhibition of Osteoclastic Bone Resorption
- (2014) Matthew Stuible et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lectin Galactoside-binding Soluble 3 Binding Protein (LGALS3BP) Is a Tumor-associated Immunomodulatory Ligand for CD33-related Siglecs
- (2014) Heinz Läubli et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interactions between Siglec-7/9 receptors and ligands influence NK cell–dependent tumor immunosurveillance
- (2014) Camilla Jandus et al. JOURNAL OF CLINICAL INVESTIGATION
- Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group BStreptococcus
- (2014) Syed Raza Ali et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia
- (2014) Ted Wun et al. PLoS One
- PILR and PILR have a siglec fold and provide the basis of binding to sialic acid
- (2014) Q. Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer
- (2014) Heinz Läubli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural basis for simultaneous recognition of an O-glycan and its attached peptide of mucin family by immune receptor PILR
- (2014) K. Kuroki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Siglec-E is a negative regulator of acute pulmonary neutrophil inflammation and suppresses CD11b 2-integrin-dependent signaling
- (2013) S. J. McMillan et al. BLOOD
- A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia
- (2013) S. H. Petersdorf et al. BLOOD
- Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
- (2013) Michael A. Morse et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology
- (2013) Catharina Steentoft et al. EMBO JOURNAL
- Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis
- (2013) Matthew S. Macauley et al. JOURNAL OF CLINICAL INVESTIGATION
- Adjuvant Ganglioside GM2-KLH/QS-21 Vaccination Versus Observation After Resection of Primary Tumor > 1.5 mm in Patients With Stage II Melanoma: Results of the EORTC 18961 Randomized Phase III Trial
- (2013) Alexander M.M. Eggermont et al. JOURNAL OF CLINICAL ONCOLOGY
- Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO—The MIMOSA Study
- (2013) Paul Sabbatini et al. JOURNAL OF CLINICAL ONCOLOGY
- CD33 Alzheimer's Risk-Altering Polymorphism, CD33 Expression, and Exon 2 Splicing
- (2013) M. Malik et al. JOURNAL OF NEUROSCIENCE
- Applying PET to Broaden the Diagnostic Utility of the Clinically Validated CA19.9 Serum Biomarker for Oncology
- (2013) N. T. Viola-Villegas et al. JOURNAL OF NUCLEAR MEDICINE
- Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non–ST-Segment Elevation Myocardial Infarction
- (2013) Jean-Claude Tardif et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Targeting Aberrant Sialylation in Cancer Cells Using a Fluorinated Sialic Acid Analog Impairs Adhesion, Migration, and In Vivo Tumor Growth
- (2013) C. Bull et al. MOLECULAR CANCER THERAPEUTICS
- Account for the 'dark matter' of biology
- (2013) Ajit Varki NATURE
- Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
- (2013) Jason E Hudak et al. Nature Chemical Biology
- T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10
- (2013) Esther Bandala-Sanchez et al. NATURE IMMUNOLOGY
- CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
- (2013) Elizabeth M Bradshaw et al. NATURE NEUROSCIENCE
- Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
- (2013) Ana Griciuc et al. NEURON
- CD22 ligand-binding and signaling domains reciprocally regulate B-cell Ca2+ signaling
- (2013) J. Muller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of PSI‐697, a Novel P‐Selectin Inhibitor, on Platelet–Monocyte Aggregate Formation in Humans
- (2013) Alan G. Japp et al. Journal of the American Heart Association
- Survival Advantage in Patients with Metastatic Breast Cancer Receiving Endocrine Therapy plus Sialyl Tn-KLH Vaccine: Post Hoc Analysis of a Large Randomized Trial
- (2013) Nuhad K. Ibrahim et al. Journal of Cancer
- Click and Pick: Identification of Sialoside Analogues for Siglec-Based Cell Targeting
- (2012) Cory D. Rillahan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study
- (2012) T. Kimura et al. Cancer Prevention Research
- Colonic Epithelial Cells Express Specific Ligands for Mucosal Macrophage Immunosuppressive Receptors Siglec-7 and -9
- (2012) K. Miyazaki et al. JOURNAL OF IMMUNOLOGY
- Density Variant Glycan Microarray for Evaluating Cross-Linking of Mucin-like Glycoconjugates by Lectins
- (2012) Kamil Godula et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
- (2012) Sylvie Castaigne et al. LANCET
- Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome
- (2012) Cory D Rillahan et al. Nature Chemical Biology
- Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance
- (2012) Ingrid G Winkler et al. NATURE MEDICINE
- Antigen Delivery to Macrophages Using Liposomal Nanoparticles Targeting Sialoadhesin/CD169
- (2012) Weihsu C. Chen et al. PLoS One
- Inhaled pan-selectin antagonist Bimosiamose attenuates airway inflammation in COPD
- (2012) Henrik Watz et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- rPSGL-Ig for Improvement of Early Liver Allograft Function: A Double-Blind, Placebo-Controlled, Single-Center Phase II Study†
- (2011) R. W. Busuttil et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Antibodies recognising sulfated carbohydrates are prevalent in systemic sclerosis and associated with pulmonary vascular disease
- (2011) T. Grader-Beck et al. ANNALS OF THE RHEUMATIC DISEASES
- Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
- (2011) C. U. Louis et al. BLOOD
- Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3
- (2011) Nicolas Porquet et al. BMC CANCER
- Human Monoclonal Antibodies to Sialyl-Lewisa (CA19.9) with Potent CDC, ADCC, and Antitumor Activity
- (2011) R. Sawada et al. CLINICAL CANCER RESEARCH
- Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction
- (2011) Guo-Yun Chen et al. NATURE BIOTECHNOLOGY
- Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
- (2011) Adam C Naj et al. NATURE GENETICS
- Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
- (2011) Paul Hollingworth et al. NATURE GENETICS
- Mining the O-glycoproteome using zinc-finger nuclease–glycoengineered SimpleCell lines
- (2011) Catharina Steentoft et al. NATURE METHODS
- Phase III Multicenter Clinical Trial of the Sialyl-TN (STn)-Keyhole Limpet Hemocyanin (KLH) Vaccine for Metastatic Breast Cancer
- (2011) D. Miles et al. ONCOLOGIST
- Efficacy of the pan-selectin antagonist Bimosiamose on ozone-induced airway inflammation in healthy subjects – A double blind, randomized, placebo-controlled, cross-over clinical trial
- (2011) Anne Kirsten et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Rolling Cell Adhesion
- (2010) Rodger P. McEver et al. Annual Review of Cell and Developmental Biology
- In vivo targeting of B-cell lymphoma with glycan ligands of CD22
- (2010) W. C. Chen et al. BLOOD
- GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice
- (2010) J. Chang et al. BLOOD
- Effects of anti-adhesive therapy on kidney biomarkers of ischemia reperfusion injury in human deceased donor kidney allografts1,2
- (2010) Chris Cheadle et al. CLINICAL TRANSPLANTATION
- YSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebo-controlled, multi-center Phase IIa study1,2,3
- (2010) A. Osama Gaber et al. CLINICAL TRANSPLANTATION
- Sialylation of 3-Methylcholanthrene-Induced Fibrosarcoma Determines Antitumor Immune Responses during Immunoediting
- (2010) M. Cohen et al. JOURNAL OF IMMUNOLOGY
- CD22 x Siglec-G Double-Deficient Mice Have Massively Increased B1 Cell Numbers and Develop Systemic Autoimmunity
- (2010) J. Jellusova et al. JOURNAL OF IMMUNOLOGY
- CD22 Is a Recycling Receptor That Can Shuttle Cargo between the Cell Surface and Endosomal Compartments of B Cells
- (2010) M. K. O'Reilly et al. JOURNAL OF IMMUNOLOGY
- Alleviation of Neurotoxicity by Microglial Human Siglec-11
- (2010) Y. Wang et al. JOURNAL OF NEUROSCIENCE
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response
- (2009) A. F. Carlin et al. BLOOD
- Synthesis of sialyl Lewisa (sLea, CA19-9) and construction of an immunogenic sLea vaccine
- (2009) Govind Ragupathi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Anti-Siglec-F Antibody Reduces Allergen-Induced Eosinophilic Inflammation and Airway Remodeling
- (2009) D. J. Song et al. JOURNAL OF IMMUNOLOGY
- From carbohydrate leads to glycomimetic drugs
- (2009) Beat Ernst et al. NATURE REVIEWS DRUG DISCOVERY
- CD24 and Siglec-10 Selectively Repress Tissue Damage-Induced Immune Responses
- (2009) G.-Y. Chen et al. SCIENCE
- Genome-wide Association Analysis Reveals Putative Alzheimer's Disease Susceptibility Loci in Addition to APOE
- (2008) Lars Bertram et al. AMERICAN JOURNAL OF HUMAN GENETICS
- E-selectin receptors on human leukocytes
- (2008) L. Nimrichter et al. BLOOD
- Human Tumor Antigens Tn and Sialyl Tn Arise from Mutations in Cosmc
- (2008) T. Ju et al. CANCER RESEARCH
- Oregovomab Maintenance Monoimmunotherapy Does Not Improve Outcomes in Advanced Ovarian Cancer
- (2008) Jonathan Berek et al. JOURNAL OF CLINICAL ONCOLOGY
- Noncovalent Cell Surface Engineering: Incorporation of Bioactive Synthetic Glycopolymers into Cellular Membranes
- (2008) David Rabuka et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
- (2008) Martin A Pule et al. NATURE MEDICINE
- Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone
- (2008) Robert Sackstein et al. NATURE MEDICINE
- Inhibition of FcεRI-dependent mediator release and calcium flux from human mast cells by sialic acid–binding immunoglobulin-like lectin 8 engagement
- (2007) Hidenori Yokoi et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More